Fundamental dimension Equity attribute | IMCPeer $8.99▲+28.43% Cap $950.2MP/E — QuantScore76/100 | CHWMLeader $5.13▼-0.77% Cap $3.20MP/E — QuantScore100/100 | CRMLPeer $6.36▲+2.75% Cap $934.2MP/E -3.4x QuantScore36/100 |
|---|---|---|---|
1. QuantScore pillars0–100 per pillar · click a ticker for the factor breakdown | |||
Technical Trend, RSI, MACD & signal consensus | |||
76/100 |
— |
25/100 |
Valuation Multiples, PEG & DCF upside | — | — | 33/100 |
Health Piotroski, Altman Z, leverage & liquidity | — | — | 27/100 |
Growth Revenue / earnings growth & margins | — | — | 60/100 |
Sentiment Analyst ratings, targets & revisions | — | 100/100 | 33/100 |
2. Valuation multiples & capital pricingGreen highlight = best-in-class (lowest positive multiple) |
Trailing P/E | — | — | -3.4x |
Forward P/E (next FY) | — | — | -29.6x |
EV / EBITDA (TTM) | — | — | -10.5x |
Price / Sales | — | — | 494.8x |
Price / Free Cash Flow | — | — | -21.9x |
PEG ratio | — | — | 0.04 |
3. Financial health & solvencyLatest filings |
Piotroski F-Score | — | — | 3 / 9 |
Altman Z-Score | — | — | 2.33 (Grey) |
Total debt / equity | — | — | 0.02 |
Quick ratio | — | — | 0.9x |
Interest coverage | — | — | -450.2x |
4. Growth & margins trajectoryLatest fiscal year |
Revenue growth YoY | — | — | +236.8% |
Net income growth YoY | — | — | -339.9% |
Gross margin (TTM) | — | — | 100.0% |
Operating margin (FY) | — | — | -3837.5% |
FCF margin (FY) | — | — | -2257.3% |
5. Trailing price performancePrice change over period |
1M return | +21.8% | -22.3% | -22.2% |
3M return | +75.2% | -22.3% | +9.5% |
6M return | +75.2% | -22.3% | -44.7% |
Year to date | +75.2% | -22.3% | -8.4% |
1Y return | +75.2% | -22.3% | -57.7% |
3Y return | +75.2% | -22.3% | -43.0% |
6. DCF valuation & street consensusDCF model · analyst consensus |
DCF model fair value | — — | — — | $0.143 -97.8% premium |
Wall Street consensus target | — — | $11.00 +114.6% · range $11.00–$11.00 | $20.00 +214.5% · range $20.00–$20.00 |
Consensus stance | — | — | 0% Buy100% Hold0% Sell |